Hijos-Mallada, G.; Saura, N.; Lué, A.; Velamazan, R.; Nieto, R.; Navarro, M.; Arechavaleta, S.; Chueca, E.; Gomollon, F.; Lanas, A.;
et al. A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. Cancers 2023, 15, 721.
https://doi.org/10.3390/cancers15030721
AMA Style
Hijos-Mallada G, Saura N, Lué A, Velamazan R, Nieto R, Navarro M, Arechavaleta S, Chueca E, Gomollon F, Lanas A,
et al. A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. Cancers. 2023; 15(3):721.
https://doi.org/10.3390/cancers15030721
Chicago/Turabian Style
Hijos-Mallada, Gonzalo, Nuria Saura, Alberto Lué, Raúl Velamazan, RocÃo Nieto, Mercedes Navarro, Samantha Arechavaleta, Eduardo Chueca, Fernando Gomollon, Angel Lanas,
and et al. 2023. "A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer" Cancers 15, no. 3: 721.
https://doi.org/10.3390/cancers15030721
APA Style
Hijos-Mallada, G., Saura, N., Lué, A., Velamazan, R., Nieto, R., Navarro, M., Arechavaleta, S., Chueca, E., Gomollon, F., Lanas, A., & Sostres, C.
(2023). A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. Cancers, 15(3), 721.
https://doi.org/10.3390/cancers15030721